Young Investigator Awards
This prize is intend to encourage the work of young investigators and is open to any scientist, of non-career grade (e.g. post doctorate or below, SpR, research fellow etc.) working in the field of rheumatology. Applicants need not to be BSR members.
These awards are supported by an Educational Grant from Schering Plough.
Past winners were:
2009
Dr. I ATCHIA
‘Musculoskeletal Ultrasound Predicts Response to Corticosteroid Injection in Moderate-Severe Hip Osteoarthritis’
Dr M BOMBARDIERI
‘Il-23 overexpression as immunological signature of subclinical intestinal inflammation in ankylosing spondylitis’
Dr E DERRETT-SMITH
‘Vasculopathy in a TGF-β; Dependent Mouse Model of Systemic Sclerosis’
Dr S HAQUE
‘Impaired endothelial progenitor cell function and early atherosclerosis in systemic lupus erythematosus (sle)’
Dr E VITAL
‘How to manage non-response to rituximab? Predictors and outcome of retreatment provide a treatment algorithm’
Ms N WEGNER
‘Endogenously citrullinated proteins from Porphyromonas gingivalis as a candidate source of priming autoantigens in rheumatoid arthritis’
2008
Dr S WRIGHT
‘A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus’
Dr V PANOULAS
‘Genetic regulation of hypertension in patients with rheumatoid arthritis’
Dr A BENNETT
‘Early inflammatory back pain and mri sacroiliitis: severity of osteitis at baseline and hla-b27 predict ankylosing spondylitis at 8 years’
Dr F HUMBY
‘activation-induced cytidine deaminase supports self sustained autoantibody production within ra synovium’
Dr K NISTALA
‘Il-17-producing t cells are enriched in the joints of children with arthritis, and correlate with clinical phenotype.’
Dr C L GORMAN
‘Polymorphisms in the cd3z gene influence tcr zeta expression in healthy controls and in sle’
2007
Dr S HAMDULAY
‘Statins and Rapamycin: Therapeutic Synergy in Vascular Cytoprotection’
Dr S CARTY
‘Combination Therapy with Etanercept and Sgp130 for Rheumatoid Arthritis Is More Effective Than Monotherapy’
Dr K WARTOLOWSKA
‘Clinical and Experimental Pain Processing In Rheumatoid Arthritis Patients Treated With Anti-TNF’
Dr H CHINOY
‘The Diagnostic Utility of Serology Testing For Predicting the Risk of Cancer-Associated Myositis’
Dr F BARONE
‘Aberrant Expression of B Cell Survival Factors in Salivary Gland’s Malt Lymphomas during Sjögren’s Syndrome’
Dr Z BETTERIDGE
‘Anti-Sumo E1: A Novel Autoantibody in Dermatomyositis Directed Against the Small Ubiquitin-Like Modifier Activating Enzyme’
2006
Dr A EL-METWALLY
‘Risk Factors for Development of Musculoskeletal Pain in Preadolescents: a Prospective’
Dr A JUDGE
‘The effects of surgical volumes and training centre status on outcomes following total joint replacement in England’
Dr R LAMB
‘Monogenic syndromes reveal candidate loci of importance for JIA susceptibility’
Dr K LUNDBERG
‘Reactivity of RA Sera with citrullinated-alpha-enolase peptides: Development of a new diagnostic elisa’
Dr K E.S. POOLE
‘A single dose of zoledronate prevents bone loss after acute stroke’
Dr J PRIOR
‘Studies on the potential of clinical acoustic emissions as a new assessment tool for knee arthritis’
2005
Dr E CLARK,
‘Bone mass in childhood is not related to measures of parental deprivation’
Dr P HO,
‘Psoriatic arthritis is associated with a Crohn’s disease gene’
Dr L JARVIS,
‘CD8+ regulatory T cells in patients with Ankylosing Spondylitis (AS)’
Dr EMILY PATTISON, ‘Environmental risk factors for the development of psoriatic arthritis: a case control study’
Dr E SMITH, ‘A novel multi-cellular model of leucocyte recruitment into the rheumatoid synovium reveals a critical role for interleukin-6’
Dr G TREHARNE,
‘Life satisfaction and depression across 1 year with Rheumatoid Arthritis: testing interactive effects of coping resources and perceived stress’
2004
Dr K ATHERTON,
‘Predicting persistence of neck pain following a motor vehicle accident: a prospective study of persons attending emergency department’
Dr N DALBETH,
‘The angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis’
Dr A KINDERLERER,
‘Upregulation of membrane-bound complement regulatory proteins by atorvastatin protects vascular endothelium against complement-mediated injury during hypoxia-reoxygenation’
Dr P PHILIPPIDIS,
‘The haemoglobin scavenger receptor CD163 mediates macrophage interleukin-10 and haem oxygenase-1 syntheseis: an inducible cytoprotective pathway against haemoglobin mediated oxidative vascular injury’
Dr K RAZA,
‘Very early rheumatoid arthritis is characterised by a unique and transient T cell and stromal cytokine profile’
Dr A TIMMS,
‘The IL1 gene cluster is a major locus determining susceptibility to ankylosing spondylitis’
2003
Dr F BARONE,
'CXCL13 and CCL21 play a key role in ectopic lymphogenesis in Sjögren’s Syndrome'
Dr M K JAVAID,
'Umbilical vein calcium concentration and maternal height predict childhood bone mineral content at nine years'
Dr G JONES,
'Physical activity and adverse psychosocial behaviour predict the onset of widespread pain in children’
Dr W KAFIENAH,
'Inhibition of cartilage degradation: a combine gene therapy and tissue engineering approach’
Dr D O'GRADAIGH,
'Cytokine-activated T-cells support osteoclastogenesis from peripheral blood mononuclear cell precursors’
Dr A LYN TAN,
'The role of metacarpophalangeal joint anatomical factors on the distribution of synovitis and bone erosion in early rheumatoid arthritis’
2002
Dr A AFUWAPE,
'Adenoviral delivery of soluble VEGF receptor (sFLT-1) abrogates disease activity in murine collagen induced arthritis’
Dr N GOODSON,
'Cardiovascular risk factors are not increased prior to the onset of inflammatory polyarthritis’
Dr E ZEGGINI,
'Development of tumour necrosis factor (TNF) polymorphism genotyping and association study with juvenile idiopathic arthritis (JIA)’
Dr R JEFFERY,
'The -174 polymorphism of IL-6 alters transcription factor binding and forms functionally significant allelic associations in systemic arthritis’
Dr J NEWTON,
'LTA-TNF halpotype studies identify additional rheumatoid arthritis susceptibility regions in the MHC’
Dr C McCARTHY,
'Knee classes are superior to home exercises in reducing pain and increasing function in patients with knee osteoarthritis: results from a randomised clinical trial’
2000
Dr C BLADES,
‘Development of a new model to investigate lymphocyte migration into human peripheral lymph nodes (HPLN) into transplanted SCID mice’
Dr M CARULLI,
‘Role of BCA-1 chemokine (CK) in the organization of follicle-like structures in Rheumatoid arthritis (RA)’
Dr K WALKER-BONE,
‘Brawn or brain? Mechanical and psychosocial risk factors for neck and upper limb musculoskeletal disorders’
Dr S LANE,
‘Is farming a risk factor for primary systemic vasculitis (PSV)?’
Dr A W MORGAN,
‘Linkage disequilibrium at the Fc gamma receptor locus and association of an Fc gamma receptor haplocyte with rheumatoid arthritis (RA) in two distinct ethnic groups’
Dr S RICHARDS,
‘The Kings Prescription Fibromyalgia Intervention Trial (KeepFit)’
2000
Dr M ALI,
‘Comparison between persistent and self-limiting synovitis by analysis of gene expression’
Dr F BIRRELL,
‘Predicting the need for total hip replacement in patients newly presenting to primary care with hip pain; a prospective cohort study’
Dr P R COLVILLE-NASH,
‘Prostaglandin F2α produced by inducible cyclooxygenase may contribute to the resolution of inflammation’
Dr L HARPER,
‘Apoptosis and its importance in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis’
Dr T LAWRENCE,
‘Inhibition of NF-B activity and MCP-1/JE release in vivo, through induction of the heat shock response’
Dr M S LILLICRAP,
‘The repertoire of human heat shock protein 60 responsive CD40+ T cell clones from a healthy individual contains more than one subset’